Frontal lobe abnormalities on MRS correlate with poor letter fluency in ALS

Neurology

Volumn 79, Issue 6, 2012, Pages 583-588

  Quinn, Colin ^a,b   Elman, Lauren ^a   McCluskey, Leo ^a   Hoskins, Katelin ^a   Karam, Chafic ^b   Woo, John H ^a   Poptani, Harish ^a   Wang, Sumei ^a   Chawla, Sanjeev ^a   Kasner, Scott E ^a   Grossman, Murray ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL ACETATE; CREATININE; CREATININE PHOSPHORIC ACID; UNCLASSIFIED DRUG;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; FEMALE; FLUENCY DISORDER; FRONTAL LOBE; FUNCTIONAL RATING SCALE SCORE; HUMAN; MALE; MOTOR PERFORMANCE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL;

EID: 84866079864     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182635720     Document Type: Article

References (36)

1. Marie P. Lecons sur les maladies de la moelle. Masson G, ed. Paris: Libraire de L'Académie de Macute]edecine de Paris; 1892:470.
2. Lomen-Hoerth C, Murphy J, Langmore S, Kramer JH, Olney RK, Miller B. Are amyotrophic lateral sclerosis patients cognitively normal? Neurology 2003;60:1094 - 1097.
3. Massman PJ, Sims J, Cooke N, Haverkamp LJ, Appel V, Appel SH. Prevalence and correlates of neuropsychological deficits in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 1996;61:450-455.
4. Hu WT, Seelaar H, Josephs KA, et al. Survival profiles of patients with frontotemporal dementia and motor neuron disease. Arch Neurol 2009;66:1359 -1364.
5. Kew JJ, Goldstein LH, Leigh PN, et al. The relationship between abnormalities of cognitive function and cerebral activation in amyotrophic lateral sclerosis: a neuropsychological and positron emission tomography study. Brain 1993;116:1399 -1423.
6. Kew JJ, Leigh PN, Playford ED, et al. Cortical function in amyotrophic lateral sclerosis: a positron emission tomography study. Brain 1993;116:655- 680.
7. Abrahams S, Leigh PN, Kew JJ, Goldstein LH, Lloyd CM, Brooks DJ. A positron emission tomography study of frontal lobe function (verbal fluency) in amyotrophic lateral sclerosis. J Neurol Sci 1995;129(suppl):44-46.
8. Abrahams S, Goldstein LH, Simmons A, et al. Word retrieval in amyotrophic lateral sclerosis: a functional magnetic resonance imaging study. Brain 2004;127:1507-1517.
9. Abrahams S, Goldstein LH, Kew JJ, et al. Frontal lobe dysfunction in amyotrophic lateral sclerosis: a PET study. Brain 1996;119:2105-2120.
10. Geser F, Martinez-Lage M, Robinson J, et al. Clinical and pathological continuum of multisystem TDP-43 proteinopathies. Arch Neurol 2009;66:180 -189.
11. Block W, Traber F, Flacke S, Jessen F, Pohl C, Schild H. In-vivo proton MR-spectroscopy of the human brain: assessment of N-acetylaspartate (NAA) reduction as a marker for neurodegeneration. Amino Acids 2002;23:317-323.
12. Kaufmann P, Pullman SL, Shungu DC, et al. Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS). Neurology 2004;62:1753-1757.
13. Unrath A, Ludolph AC, Kassubek J. Brain metabolites in definite amyotrophic lateral sclerosis: a longitudinal proton magnetic resonance spectroscopy study. J Neurol 2007;254:1099 -1106.
14. Wang S, Poptani H, Woo JH, et al. Amyotrophic lateral sclerosis: diffusion-tensor and chemical shift MR imaging at 3.0 T. Radiology 2006;239:831- 838.
15. Abe K, Takanashi M, Watanabe Y, et al. Decrease in Nacetylaspartate/ creatine ratio in the motor area and the frontal lobe in amyotrophic lateral sclerosis. Neuroradiology 2001;43:537-541.
16. Abrahams S, Leigh PN, Harvey A, Vythelingum GN, Grise D, Goldstein LH. Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS). Neuropsychologia 2000;38:734 -747.
17. Gallassi R, Montagna P, Ciardulli C, Lorusso S, Mussuto V, Stracciari A. Cognitive impairment in motor neuron disease. Acta Neurol Scand 1985;71:480-484.
18. Abe K, Fujimura H, Toyooka K, Sakoda S, Yorifuji S, Yanagihara T. Cognitive function in amyotrophic lateral sclerosis. J Neurol Sci 1997;148:95-100.
19. Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293-299.
20. Abrahams S, Leigh PN, Goldstein LH. Cognitive changein ALS: a prospective study. Neurology 2005;64:1222-1226.
21. Ebel A, Soher BJ, Maudsley AA. Assessment of 3D proton MR echo-planar spectroscopic imaging using automated spectral analysis. Magn Reson Med 2001;46:1072-1078.
22. Maudsley AA, Domenig C, Govind V, et al. Mapping of brain metabolite distributions by volumetric proton MR spectroscopic imaging (MRSI). Magn Reson Med 2009; 61:548 -559.
23. Maudsley AA, Darkazanli A, Alger JR, et al. Comprehensive processing, display and analysis for in vivo MR spectroscopic imaging. NMR Biomed 2006;19:492-503.
24. Massman PJ, Sims J, Cooke N, Haverkamp LJ, Appel V, Appel SH. Prevalence and correlates of neuropsychological deficits in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 1996;61:450-455.
25. Milner B. Some effects of frontal lobectomy in man. In: Warren JM, Akert K, eds. The Frontal Granular Cortex and Behavior. New York: McGraw-Hill; 1964;313-331.
26. Stuss DT, Levine B. Adult clinical neuropsychology: lessons from studies of the frontal lobes. Annu Rev Psychol 2002;53:401- 433.
27. Abrahams S, Goldstein LH, Simmons A, et al. Functional magnetic resonance imaging of verbal fluency and confrontation naming using compressed image acquisition to permit overt responses. Hum Brain Mapp 2003;20: 29 - 40.
28. Sanjuan A, Bustamante JC, Forn C, et al. Comparison of two fMRI tasks for the evaluation of the expressive language function. Neuroradiology 2010;52:407- 415.
29. Libon DJ, McMillan C, Gunawardena D, et al. Neurocognitive contributions to verbal fluency deficits in frontotemporal lobar degeneration. Neurology 2009;73:535-542.
30. Strong MJ, Grace GM, Freedman M, et al. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2009;10:131-146.
31. Talbot PR, Goulding PJ, Lloyd JJ, Snowden JS, Neary D, Testa HJ. Inter-relation between "classic" motor neuron disease and frontotemporal dementia: neuropsychological and single photon emission computed tomography study. J Neurol Neurosurg Psychiatry 1995;58:541-547.
32. Rippon GA, Scarmeas N, Gordon PH, et al. An observational study of cognitive impairment in amyotrophic lateral sclerosis. Arch Neurol 2006;63:345-352.
33. Rakowicz WP, Hodges Jr. Dementia and aphasia in motor neuron disease: an underrecognised association? J Neurol Neurosurg Psychiatry 1998;65:881- 889.
34. Gordon PH, Wang Y, Doorish C, et al. A screening assessment of cognitive impairment in patients with ALS. Amyotroph Lateral Scler 2007;8:362-365.
35. Wicks P, Abrahams S, Leigh PN, Williams T, Goldstein LH. Absence of cognitive, behavioral, or emotional dysfunction in progressive muscular atrophy. Neurology 2006;67:1718 -1719.
36. Raaphorst J, de Visser M, van Tol MJ, et al. Cognitive dysfunction in lower motor neuron disease: executive and memory deficits in progressive muscular atrophy. J Neurol Neurosurg Psychiatry 2011;82:170 -175.